SEC Comment Letter 0000000000-24-011494 to CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Date: Oct. 10, 2024 · CIK: 0001187953 · Accession: 0000000000-24-011494
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282512
Letter
October 10, 2024 Timothy Warbington Chief Executive Officer Creative Medical Technology Holdings, Inc. 211 E. Osborn Road Phoenix, AZ 85012 Re:Creative Medical Technology Holdings, Inc. Registration Statement on Form S-3 Filed October 4, 2024 File No. 333-282512 Dear Timothy Warbington: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Zev M. Bomrind, Esq.
Show Raw Text
October 10, 2024
Timothy Warbington
Chief Executive Officer
Creative Medical Technology Holdings, Inc.
211 E. Osborn Road
Phoenix, AZ 85012
Re:Creative Medical Technology Holdings, Inc.
Registration Statement on Form S-3
Filed October 4, 2024
File No. 333-282512
Dear Timothy Warbington:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Zev M. Bomrind, Esq.